PDCD1LG2 and neoplasm: Unlike the PD-1 antibodies, the PD-L1 antibodies also block the PD-1/PD-L1 and PD-L1/CD80 axes but leave the PD-L2/PD-1 axis unaffected, leading to tumor immune escape [28].